Portage Biotech Inc.

NASDAQ: PRTG · Real-Time Price · USD
8.55
-0.25 (-2.84%)
At close: Aug 15, 2025, 3:59 PM
8.57
0.23%
After-hours: Aug 15, 2025, 07:52 PM EDT

Portage Biotech Income Statement

Financials in USD. Fiscal year is April - March.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020
Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a 8K 13K 15K 15K 11K n/a 1K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit
n/a -8K -13K -15K -15K -11K n/a -1K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Income
-1.6M -2.84M -3.25M -4.03M -5.93M -5M -4.08M -4.76M -3.65M -4.09M -4.5M -4.17M -3.33M -3.59M -9.43M -866K -1.17M -973K
Interest Income
24K 45K 60K 75K 53K 80K 102K 50K 44K 21K n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-1.36M -1.66M -24.91M -48.88M -6.07M -6.07M -109.41M -5.3M -3.64M -4.18M -4.05M -4.09M -3.38M -3.3M -10.2M -1.42M -2.69M -655K
Net Income
-1.36M -1.66M -24.89M -39.37M -5.16M -5.92M -94.45M -7.49M -949K -1.73M -7.32M -3.51M -2.98M -3.07M -11.5M -1.18M -2.46M -696K
Selling & General & Admin
881K 1.53M 1.35M 1.25M 1.69M 1.37M 1.84M 2.22M 2.09M 2.21M 2.53M 2.24M 2M 2.05M 3.78M 452K 376K 521K
Research & Development
723K 1.3M 1.9M 2.77M 4.24M 3.63M 2.24M 2.54M 1.56M 1.88M 1.97M 1.93M 1.33M 1.55M 5.72M 414K 792K 452K
Other Expenses
n/a n/a n/a n/a 15K 11K n/a 1K n/a n/a n/a n/a n/a n/a -65K n/a n/a n/a
Operating Expenses
1.6M 2.84M 3.25M 4.03M 5.95M 5.01M 4.08M 4.76M 3.65M 4.09M 4.5M 4.17M 3.33M 3.59M 9.43M 866K 1.17M 973K
Interest Expense
n/a n/a 7K 9K 10K n/a n/a n/a 9K n/a 1K 1K 7K 34K 5K 3K 47K 122K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
1.6M 2.84M 3.26M 4.04M 5.95M 5.01M 4.08M 4.76M 3.65M 4.09M 4.5M 4.17M 3.33M 3.59M 9.43M 866K 1.17M 973K
Income Tax Expense
n/a 2K 1K -9.5M -907K -145K -14.95M 2.2M -2.55M -2.55M 4.82M 117K -503K -79K 2.3M -65K 701K n/a
Shares Outstanding (Basic)
1.08M 1.05M 19.78M 20.9M 17.8M 17.7M 17.61M 17.04M 15.2M 13.35M 13.06M 13.34M 13.33M 12.21M 12.03M 12.03M 11.69M 11.1M
Shares Outstanding (Diluted)
1.08M 1.05M 19.78M 20.9M 17.8M 17.7M 17.61M 17.04M 16.74M 13.35M 13.06M 13.34M 13.33M 12.21M 12.03M 12.03M 11.69M 11.1M
EPS (Basic)
-1.26 -1.58 -1.26 -1.88 -0.29 -0.33 -5.36 -0.44 -0.06 -0.13 -0.56 -0.26 -0.22 -0.25 -0.96 -0.1 -0.21 -0.06
EPS (Diluted)
-1.26 -1.58 -1.26 -1.88 -0.29 -0.33 -5.36 -0.44 -0.06 -0.13 -0.56 -0.26 -0.22 -0.25 -0.96 -0.1 -0.21 -0.06
EBITDA
-1.6M -2.84M -24.89M -48.72M -6.01M -5M -109.41M -4.76M -3.63M -4.09M -5.25M -4.09M -3.37M -3.27M -15.64M -845K -2.59M -533K
EBIT
-1.61M -2.85M -24.9M -48.73M -5.95M -5.01M -109.41M -5.15M -3.63M -4.12M -3.98M -4.09M -3.37M -3.27M -9.25M -1.41M -2.64M -973K
Depreciation & Amortization
7K 8K 13K 15K 15K 11K -7.74M 1K 3.65M -3.76M -1.12M 4.17M 3.33M 3.59M -3.58M 866K 1.17M 1.54M